Equity Ab Frankenius is 10% Owner at TriSalus Life Sciences, Inc. (TLSI). They have made 1 open-market trade across 1 company since 2024, most recently 2024-12-17.
CIK 0001988262
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $500K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TLSI | 6,230,748 | $22.7M |
Shares reported on the most recent Form 4, priced at the 2024-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLSI | BUY | 2024-12-17 | 2024-12-19 | $3.97 | $500K | +32.8% | +29.6% | +41.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.